177 related articles for article (PubMed ID: 33218896)
61. Design and synthesis of new coumarin hybrids and insight into their mode of antiproliferative action.
Elshemy HAH; Zaki MA
Bioorg Med Chem; 2017 Feb; 25(3):1066-1075. PubMed ID: 28038941
[TBL] [Abstract][Full Text] [Related]
62. Coumarins as Potential Anti-drug Resistant Cancer Agents: A Mini Review.
Wang G; Sun S; Wu B; Liu J
Curr Top Med Chem; 2021; 21(19):1725-1736. PubMed ID: 33185162
[TBL] [Abstract][Full Text] [Related]
63. Design, Synthesis, and Evaluation of in Vitro and in Vivo Anticancer Activity of 4-Substituted Coumarins: A Novel Class of Potent Tubulin Polymerization Inhibitors.
Cao D; Liu Y; Yan W; Wang C; Bai P; Wang T; Tang M; Wang X; Yang Z; Ma B; Ma L; Lei L; Wang F; Xu B; Zhou Y; Yang T; Chen L
J Med Chem; 2016 Jun; 59(12):5721-39. PubMed ID: 27213819
[TBL] [Abstract][Full Text] [Related]
64. ROS Inhibitory Activity and Cytotoxicity Evaluation of Benzoyl, Acetyl, Alkyl Ester, and Sulfonate Ester Substituted Coumarin Derivatives.
Salar U; Khan KM; Jabeen A; Faheem A; Naqvi F; Ahmed S; Iqbal E; Ali F; Kanwal ; Perveen S
Med Chem; 2020; 16(8):1099-1111. PubMed ID: 31448715
[TBL] [Abstract][Full Text] [Related]
65. Some new indole-coumarin hybrids; Synthesis, anticancer and Bcl-2 docking studies.
Kamath PR; Sunil D; Ajees AA; Pai KS; Das S
Bioorg Chem; 2015 Dec; 63():101-9. PubMed ID: 26469742
[TBL] [Abstract][Full Text] [Related]
66. Structure-based design of N-substituted 1-hydroxy-4-sulfamoyl-2-naphthoates as selective inhibitors of the Mcl-1 oncoprotein.
Lanning ME; Yu W; Yap JL; Chauhan J; Chen L; Whiting E; Pidugu LS; Atkinson T; Bailey H; Li W; Roth BM; Hynicka L; Chesko K; Toth EA; Shapiro P; MacKerell AD; Wilder PT; Fletcher S
Eur J Med Chem; 2016 May; 113():273-92. PubMed ID: 26985630
[TBL] [Abstract][Full Text] [Related]
67. Synthesis and biological evaluation of isoprenylated coumarins as potential anti-pancreatic cancer agents.
Jun M; Bacay AF; Moyer J; Webb A; Carrico-Moniz D
Bioorg Med Chem Lett; 2014 Oct; 24(19):4654-4658. PubMed ID: 25205194
[TBL] [Abstract][Full Text] [Related]
68. Synthesis and anticancer activities of some new coumarin derivatives including the triazole ring and their in silico molecular docking studies.
Menteşe E; Güner A; Polatlı E; Emirik M; Bektaş H; Kahveci B
Arch Pharm (Weinheim); 2021 Mar; 354(3):e2000284. PubMed ID: 33146895
[TBL] [Abstract][Full Text] [Related]
69. Synthesis and biological evaluation of new coumarins bearing 2,4-diaminothiazole-5-carbonyl moiety.
Ayati A; Oghabi Bakhshaiesh T; Moghimi S; Esmaeili R; Majidzadeh-A K; Safavi M; Firoozpour L; Emami S; Foroumadi A
Eur J Med Chem; 2018 Jul; 155():483-491. PubMed ID: 29908441
[TBL] [Abstract][Full Text] [Related]
70. Benzazole Substituted Iminocoumarins as Potential Antioxidants with Antiproliferative Activity.
Perin N; Cindrić M; Vervaeke P; Liekens S; Mašek T; Starčević K; Hranjec M
Med Chem; 2021; 17(1):13-20. PubMed ID: 31849290
[TBL] [Abstract][Full Text] [Related]
71. Synthesis of novel building blocks of benzosuberone bearing coumarin moieties and their evaluation as potential anticancer agents.
Yadagiri B; Holagunda UD; Bantu R; Nagarapu L; Kumar CG; Pombala S; Sridhar B
Eur J Med Chem; 2014 May; 79():260-5. PubMed ID: 24742385
[TBL] [Abstract][Full Text] [Related]
72. Design, Synthesis, and In Vitro Evaluation of Novel 3, 7-Disubstituted Coumarin Derivatives as Potent Anticancer Agents.
Wang Y; Liu H; Lu P; Mao R; Xue X; Fan C; She J
Chem Biol Drug Des; 2015 Oct; 86(4):637-47. PubMed ID: 25626768
[TBL] [Abstract][Full Text] [Related]
73. Discovery of novel coumarin-based KRAS-G12C inhibitors from virtual screening and Rational structural optimization.
Shi JT; Hou SJ; Cheng L; Zhang HJ; Mu HX; Wang QS; Wang ZY; Chen SW
Bioorg Chem; 2024 Jul; 148():107467. PubMed ID: 38772290
[TBL] [Abstract][Full Text] [Related]
74. Fragment-Based Design, Synthesis, and Biological Evaluation of 1-Substituted-indole-2-carboxylic Acids as Selective Mcl-1 Inhibitors.
Wang Z; Xu W; Song T; Guo Z; Liu L; Fan Y; Wang A; Zhang Z
Arch Pharm (Weinheim); 2017 Jan; 350(1):. PubMed ID: 27911011
[TBL] [Abstract][Full Text] [Related]
75. Synthesis and biological evaluation of novel 4,7-dihydroxycoumarin derivatives as anticancer agents.
Govindaiah P; Dumala N; Grover P; Jaya Prakash M
Bioorg Med Chem Lett; 2019 Jul; 29(14):1819-1824. PubMed ID: 31104996
[TBL] [Abstract][Full Text] [Related]
76. Anti-breast Cancer Potential of Natural and Synthetic Coumarin Derivatives.
Song F; Huo X; Guo Z
Curr Top Med Chem; 2021; 21(18):1692-1709. PubMed ID: 33655862
[TBL] [Abstract][Full Text] [Related]
77. Design, synthesis, in vitro antiproliferative activity and apoptosis-inducing studies of 1-(3',4',5'-trimethoxyphenyl)-3-(2'-alkoxycarbonylindolyl)-2-propen-1-one derivatives obtained by a molecular hybridisation approach.
Preti D; Romagnoli R; Rondanin R; Cacciari B; Hamel E; Balzarini J; Liekens S; Schols D; Estévez-Sarmiento F; Quintana J; Estévez F
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1225-1238. PubMed ID: 30141353
[TBL] [Abstract][Full Text] [Related]
78. Synthesis and cytotoxic activity of non-naturally substituted 4-oxycoumarin derivatives.
Serra S; Chicca A; Delogu G; Vázquez-Rodríguez S; Santana L; Uriarte E; Casu L; Gertsch J
Bioorg Med Chem Lett; 2012 Sep; 22(18):5791-4. PubMed ID: 22901895
[TBL] [Abstract][Full Text] [Related]
79. Synthesis of mitochondria-targeted coumarin-3-carboxamide fluorescent derivatives: Inhibiting mitochondrial TrxR2 and cell proliferation on breast cancer cells.
Li Y; Tang Q; Xie Y; He D; Yang K; Zheng L
Bioorg Med Chem Lett; 2021 Feb; 33():127750. PubMed ID: 33340662
[TBL] [Abstract][Full Text] [Related]
80. Impact of elevated anti-apoptotic MCL-1 and BCL-2 on the development and treatment of MLL-AF9 AML in mice.
Anstee NS; Bilardi RA; Ng AP; Xu Z; Robati M; Vandenberg CJ; Cory S
Cell Death Differ; 2019 Jul; 26(7):1316-1331. PubMed ID: 30470795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]